Evidence map›Paper›PMID 18843705›Full record

SynthesisThe Cochrane database of systematic reviews2008

Probiotics for treating eczema.

Robert John Boyle, Fiona J Bath-Hextall, Jo Leonardi-Bee, Dedee F Murrell, Mimi Lk Tang

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 6 pooled it
22.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 6 syntheses or guidelines pooled it, 230 citations in OpenAlex.

  1. Pooled it
  2. Probiotics for treating eczema.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Emollients and moisturisers for eczema.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Pooled it
  5. House dust mite reduction and avoidance measures for treating eczema.The Cochrane database of systematic reviews · 2015
    Pooled it
  6. Dietary supplements for established atopic eczema.The Cochrane database of systematic reviews · 2012
    Pooled it
  7. Effects ofJournal of Korean medical science · 2020
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Dietary modifications in atopic dermatitis: patient-reported outcomes.The Journal of dermatological treatment · 2017
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Robert John BoyleAllergy and Clinical Immunology, Royal Children's Hospital, Flemington Road, Parkville, Victoria, Australia, 3052. r.boyle@pgrad.unimelb.edu.au
Fiona J Bath-Hextall
Jo Leonardi-Bee
Dedee F Murrell
Mimi Lk Tang
Royal Children's Hospital · AUUniversity of Nottingham · GBSt George Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProbiotics have been proposed as an effective treatment for eczema, and recently a number of clinical trials have been undertaken.

objectivesTo assess the effects of probiotics for the treatment of eczema SEARCH STRATEGY: We searched the Cochrane Skin Group Specialised Register (to April 2008), the Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 2,2008) MEDLINE (from 2003 to April 2008), EMBASE (from 2005 to April 2008), PsycINFO, AMED and LILACS (from inception to April 2008) and ISI Web of Science (to December 2006) and reference lists of articles. We also searched registries of ongoing clinical trials, conference proceedings and searched for adverse events. SELECTION CRITERIA: Randomised controlled trials of live orally ingested microorganisms for the treatment of eczema. DATA COLLECTION AND ANALYSIS: Two authors independently applied eligibility criteria, assessed the quality of trials and extracted data. We contacted study authors for more information where necessary. We recorded adverse events from the included studies, and from the separate adverse events search. MAIN

resultsTwelve randomised controlled trials involving 781 participants met the inclusion criteria. All trial participants were children. There was no significant difference in participant or parent-rated symptom scores in favour of probiotic treatment (5 trials, 313 participants). Symptom severity on a scale from 0 to 20 was 0.90 points lower after probiotic treatment than after placebo (95%CI -1.04, 2.84; p = 0.36).There was also no significant difference in participant or parent-rated overall eczema severity in favour of probiotic treatment (3 trials, 150 participants). There was no significant difference in investigator rated eczema severity between probiotic and placebo treatments (7 trials, 588 participants). On a scale from 0 to 102 investigator rated eczema severity was 2.46 points lower after probiotic treatment than after placebo treatment (95%CI -2.53, 7.45 p = 0.33). Significant heterogeneity was noted between the results of individual studies, which may be explained by the use of different probiotic strains. Subgroup analysis by age of participant, severity of eczema, presence of atopy or presence of food allergy did not identify a population with different treatment outcomes to the population as a whole. The adverse events search identified some case reports of infections and bowel ischaemia caused by probiotics. AUTHORS'

conclusionsThe evidence suggests that probiotics are not an effective treatment for eczema, and probiotic treatment carries a small risk of adverse events.

Indexed as

ChildEczemaHumansProbioticsRandomized Controlled Trials as TopicTreatment Outcome

Identifiers

PMID18843705
OpenAlexW1747966476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.